Each measured tryptic peptide of synaptotagmin-1 (215–223 and 238–245) could differentiate dementia due to Alzheimer’s disease from controls and MCI due to Alzheimer’s disease from controls to a similar magnitude, in the respective sample sets. The gene discussed is SYT1; the disease is Alzheimer disease.